{"id":"NCT00976209","sponsor":"Bayer","briefTitle":"Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)","officialTitle":"A Randomized, Two-Way Crossover, Multicenter, Consumer Preference Study of Two Oral Formulations of Phenylephrine Hydrochloride.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-08","primaryCompletion":"2009-11","completion":"2009-11","firstPosted":"2009-09-14","resultsPosted":"2011-03-25","lastUpdate":"2015-03-11"},"enrollment":331,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Vasomotor Rhinitis","Seasonal Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"Phenylephrine Hydrochloride (HCl) Extended Release (ER) Tablets 30 mg","otherNames":[]},{"type":"DRUG","name":"Phenylephrine Hydrochloride (HCl) Immediate Release (IR) tablets, 10 mg","otherNames":["Sudafed PE®"]}],"arms":[{"label":"Phenylephrine Hydrochloride Extended Release Tablets, 30 mg","type":"EXPERIMENTAL"},{"label":"Phenylephrine Hydrochloride Immediate Release Tablets, 10 mg","type":"ACTIVE_COMPARATOR"}],"summary":"This is a randomized, two-way crossover, multicenter study evaluating the consumer preference of Phenylephrine Extended Release Tablets, 30 mg to be taken as one tablet every 12 hours, or Phenylephrine Immediate Release Tablets, 10 mg to be taken as one tablet every 4 hours in subjects with at least mild allergic rhinitis and nasal congestion. Approximately 250 participants will complete a questionnaire after taking one test product for 3 days followed by a 3 day (± 1 day) washout period; and then taking the alternate test product for 3 days. Analysis of which product the consumer preferred, if any, and which product was more convenient, if any, will be evaluated.","primaryOutcome":{"measure":"Percentage of Participants That Preferred Phenylephrine HCl 30 mg Extended Release Tablets, as Compared to Phenylephrine HCl 10 mg Immediate Release Tablets for the Relief of Nasal Congestion","timeFrame":"Visit 6 (Period 2, Day 4)","effectByArm":[{"arm":"All Participants","deltaMin":55,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":10},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":327},"commonTop":[]}}